Mitoxantrone-related acute leukemia in two MS patients

Acta Neurologica Belgica

Volumn 108, Issue 3, 2008, Pages 99-102

  Pielen, A ^a   Goffette, S ^a   van Pesch, V ^a   Gille, M ^b   Sindic, C J M ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Brussels Saint Elisabeth Clinic   (Belgium)

Author keywords

Immunosuppression; Leukemia; Mitoxantrone; Multiple sclerosis

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; METHOTREXATE; MITOXANTRONE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; ATAXIA; CASE REPORT; CHROMOSOME 15Q; CHROMOSOME 17Q; CHROMOSOME 21Q; CHROMOSOME 8Q; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; FEMALE; HEMIPARESIS; HUMAN; MALE; MULTIPLE SCLEROSIS; SENSORY DYSFUNCTION; SPASTIC PARESIS; TREATMENT REFUSAL;

EID: 57549089217     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ARRUDA W. O., MONTU M. B., DE SOUZA DE OLIVEIRA M., RAMINA R. Acute myeloid leukaemia induced by mitoxantrone. Arq. Neuropsiquiatr., 2005, 63: 327-329.
2. BEAUMONT M., SANZ M., CARLI P. M., MALOISEL F., THOMAS X. et al. Therapy-related actue promyelocytic leukemia. J. Clin. Oncol., 2003, 21: 2123-2137.
3. BRASSAT D., RECHER C., WAUBANT E, LE PAGE E., RIGALHUGUET F. et al. Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS. Neurology, 2002, 59: 954-955.
4. CARTWRIGHT M. S., JEFFERY D. R., LEWIS Z. T., KOTY P. P., STEWART W.T. et al. Mitoxantrone for multiple sclerosis causing acute lymphoblastic leukemia. Neurology, 2007, 68: 1630-1631.
5. CATTANEO C., ALMICI C., BORLENGHI E., MOTTA M., ROSSI G. A case of acute promyelocytic leukaemia following mitoxantrone treatment of multiple sclerosis. Leukemia, 2003, 17: 985-986.
6. CORDIOLI C., CATTANEO C., ROSSI G., CAPRA R. Analysis of incidence, risk factors and prognosis of acute promyelocytic leukaemia related to mitoxantrone therapy in multiple sclerosis patients. Neurology, 2007, 68 (suppl. 1) A276.
7. DELISSE B., DE SEZE J., MACKOWIAK A., N'KENDJUO J. B., VERIER A. et al. Therapy related acute myeloblastic leukaemia after mitoxantrone treatment in a patient with multiple sclerosis. Mult. Scler., 2004, 10: 92.
8. GHALIE R. G., MAUCH E., EDAN G., HARTUNG H. P., GONSETTE R. E. et al. A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis. Mult. Scler., 2002, 8: 441-445.
9. GOFFETTE S., VAN PESCH V., VANOVERSCHELDE J. L., MORANDINI E., SINDIC C.J.M. Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone. J. Neurol., 2005, 252:1217-1222.
10. GOODKIN D. E. Therapy-related leukemia in mitozantrone treated patients. Mult. Scler., 2003, 9: 426.
11. HEESEN C., BRUEGMANN M., GBDAMOSI J., KOCH E., MÖNCH A. et al. Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone. Mult. Scler., 2003, 9: 213-214.
12. LEDDA A., CAOCCI G., SPINICCI G., COCCO E., MAMUSA E. et al. Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patiems with multiple sclerosis. Leukemia, 2006, 20: 2217-2218.
13. LE PAGE E., LERAY E., TAURIN G., COUSTANS M., CHAPERON J. et al. Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: Treatment response factors in a 5 year follow-up observational study of 100 consecutive patients. J. Neurol. Neurosurg. Psych., 2008, 79: 52-56.
14. LINASSIER C., BARIN C., CALAIS G., LETORTOREC S., BREMOND J. L. et al. Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphasmide, fluorouracil and radiation therapy. Annals of Oncology, 2000, 11: 1289-1294.
15. LYNN D. J., BLUM W., CATALAND S., RAMMOHAN K. W. Multiple sclerosis and mitoxantrone treatment-related leukemia: A single center experience. Neurology, 2006, 66 (Suppl. 2): PA31.
16. MISTRY A. R., FELIX C. A., WHITMARSH R. J., MASON A., REITERA. et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N. Engl. J. Med., 2005, 352: 1529-1538.
17. NOLLET S., BERGER E., DECONINCK E., BALDAUF E., RUMBACH L. Leucémies aiguës chez deux patients atteints de sclérose en plaques et traités par mitoxantrone. Rev. Neurol. 2006, 162: 195-199.
18. NOVOSELAC A. V., REDDY S., SANMUGARAJAH J. Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone. Leukemia, 2004, 18: 1561-1562.
19. RADU T. D., MARC D., HERVE V. Acute myeloid leukaemia (AML) induced by mitoxantrone. Mult. Scler., 2002, 8: P342, S127
20. RAMKUMAR B., CHADHA M. K., BARCOS M., SAIT S. N. J., HEYMAN M. R., BAER M. R. Acute promyelocytic leukaemia after mitoxantrone therapy for multiple sclerosis. Cancer Gen. Cytogen., 2008, 182: 126-129
21. RAMTAHAL J., JACOB A., DAS K., BOGGILD M. Sequential maintenance treatment with glatiramer acetate after mitoxantrone is safe and can limit exposure to immuno-suppression in very active, relapsing remitting multiple sclerosis. J. Neurol., 2006, 253: 1160-1164.
22. SADIQ S. A., RAMMAL M., SARA G. Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MS. Mult. Scler., 2008, 14: 272-273.
23. TANASESCU R., DEBOUVERIE M., PITTION S., ANXIONNAT R., VESPIGNANI H. Acute myeloid leukaemia induced by mitoxantrone in a multiple sclerosis patient. J. Neurol., 2004, 251: 762-763.
24. TELLEZ N., RIO J., TINTORE M., ROVIRA A., NOC C. et al. Mitoxantrone in MS patients, non-responders to interferon. Mult. Scler., 2005, S172, P. 647 (abstract).
25. VICARI A. M., CICERI F., FOLLI F. et al. Acute promyelocytic leukemia following mitoxantrone as single agent for the treatment of multiple sclerosis. Leukemia, 1998, 12: 441-442.
26. VOLTZ R., STARCK M., ZINGLER V., STRUPP M., KOLB H. J. Mitoxantrone therapy in multiple sclerosis and acute leukeamia: A case report out of 644 treated patients. Mult. Scler., 2004, 10: 472-474.